Abstract:The hypothesis that neurotoxins may play a role in neurodegenerative disorders remains an elusive one, given that epidemiologic studies often provide conflicting results. Although these conflicting results may result from methodological differences within and between studies, the complexity of chemical disruption of the central nervous system cannot be ignored in attempts to evaluate this hypothesis in different neurodegenerative disorders. Spencer provides a detailed review of the complex processes involved in defining the neurotoxic potential of naturally occurring and synthetic agents. Even concepts such as exposure and dose, as often reported in studies attempting to evaluate the risk imparted by a potential compound, can be deceptive. For example, although dose reflects "that amount of chemical transferred to the exposed subject", factors such as time and concentration in the organism, the ability to access the central nervous system, and how a compound reaches the central nervous system (routes of administration) or secondarily affects other organ systems leading to central nervous system disruption are clearly important to the concept of neurotoxic risk in neurodegenerative disorders. These factors would appear to explain the observed disagreements between studies using animal or neuronal models of neurotoxicity and population-based studies in humans. The importance of these factors and how a potential neurotoxin is investigated are clearly seen in the data on AD and aluminum. In contrast, the impact of MTPT on the central nervous system is more direct and compelling. Added complexity in the study of neurotoxins in human neurodegeneration is derived from data showing that agents may have additive, potentiating, synergistic, or antagonistic effects. Therefore, data from studies evaluating EMF risks could be readily confounded by the presence or absence of heavy metals (eg, arc welding). Other factors that may conceal neurotoxic causes for a given disorder focus on additional features such as genetic predispositions, physiologic changes that occur in aging, and even nutritional status that can support or hinder the affect of a given agent on the central nervous system. Finally, many studies that investigate exposure risk do not readily incorporate the five criteria proposed by Schaumburg for establishing causation. For example, if we apply Schaumburg's first criterion, epidemiologic studies often determines the presence of an agent through history, yet they cannot readily confirm exposure based on environmental or clinical chemical analyses to fulfill this criterion for causation. Additional limitations in research design along with the populations and methods that are sued to study neurotoxins in human neurodegenerative disorders often fail to meet other criteria such as linking the severity and onset with duration and exposure level. Therefore, although studies of agents such as MTPT provide compelling models of neurotoxins and neurodegeneration in humans, disorders such as ALS, PD, and particularly AD will require additional effort if research is to determine the contribution (presence or absence) of neurotoxins to these neurologic disorders.

Toxic and Drug-Related White Matter Diseases of the Brain and Spine

Toxic and metabolic leukoencephalopathies in emergency department patients: a primer for the radiologist

Toxic leukoencephalopathies

Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients

Infectious leukoencephalopathies

Neurodegenerative memory disorders: a potential role of environmental toxins

Imaging Features of Toxic Encephalopathy and the Values of DWI

Insights into the Neurodegenerative Process of Alzheimer's Disease: a Role for Mononuclear Phagocyte-Associated Inflammation and Neurotoxicity

Demyelination as a rational therapeutic target for ischemic or traumatic brain injury.

Spinal Cord Toxicity from Intrathecal Chemotherapy: A Case with Clinicopathologic Correlation

Methamphetamine-induced Toxic Leukoencephalopathy: Clinical, Radiological and Autopsy Findings

Not-So-Normal-Appearing White Matter

Traumatic white matter injury and glial activation: from basic science to clinics.

Infectious Diseases of the Brain and Spine: Parasitic and Other Atypical Transmissible Diseases

Toxicologic Neuropathology of Novel Biotherapeutics

Infectious Diseases of the Brain and Spine

5 cases analysis of toxic encephalopathy induced by organic solvents

Treatment-related leukoencephalopathy in adults with central nervous system lymphoma: a retrospective analysis of 126 patients

In the Kingdom of Triphasic Waves, White Matter Is the Eminence Grise

From spreading depolarization to blood-brain barrier dysfunction: navigating traumatic brain injury for novel diagnosis and therapy

Post-traumatic neurodegeneration and chronic traumatic encephalopathy